| Age |
15 |
33.0 (29.5, 36.0) |
| Unknown |
|
24 |
| Male |
11 |
|
| 0 |
|
6 (55%) |
| 1 |
|
5 (45%) |
| Unknown |
|
28 |
| Live |
39 |
|
| 0 |
|
19 (49%) |
| 1 |
|
20 (51%) |
| IUFD |
39 |
|
| 0 |
|
30 (77%) |
| 1 |
|
9 (23%) |
| TermLive |
38 |
|
| 0 |
|
36 (95%) |
| 1 |
|
2 (5.3%) |
| Unknown |
|
1 |
| Miscariage/TOPbeforeviableage |
39 |
|
| 0 |
|
32 (82%) |
| 1 |
|
7 (18%) |
| Preterm(Viableage)delivery |
38 |
|
| 0 |
|
9 (24%) |
| 1 |
|
29 (76%) |
| Unknown |
|
1 |
| IUGR/growthrestriction |
31 |
|
| 0 |
|
5 (16%) |
| 1 |
|
26 (84%) |
| Unknown |
|
8 |
| placenta<10% |
14 |
|
| 0 |
|
1 (7.1%) |
| 1 |
|
13 (93%) |
| Unknown |
|
25 |
| Hypertensivedosierdersofpregnancy |
5 |
|
| 0 |
|
3 (60%) |
| 1 |
|
2 (40%) |
| Unknown |
|
34 |
| autoimmune/allergy/hypersensitivity |
1 |
|
| 1 |
|
1 (100%) |
| Unknown |
|
38 |
| Treatment |
8 |
|
| 0 |
|
4 (50%) |
| 1 |
|
4 (50%) |
| Unknown |
|
31 |
| IVIG |
8 |
|
| 0 |
|
7 (88%) |
| 1 |
|
1 (13%) |
| Unknown |
|
31 |
| Prednisolone |
8 |
|
| 0 |
|
6 (75%) |
| 1 |
|
2 (25%) |
| Unknown |
|
31 |
| LMWH/heparin |
8 |
|
| 0 |
|
6 (75%) |
| 1 |
|
2 (25%) |
| Unknown |
|
31 |
| ASA |
8 |
|
| 0 |
|
4 (50%) |
| 1 |
|
4 (50%) |
| Unknown |
|
31 |
| increasedAlkp |
6 |
|
| 0 |
|
1 (17%) |
| 1 |
|
5 (83%) |
| Unknown |
|
33 |